Page last updated: 2024-09-03

3-ft and Bladder Cancer

3-ft has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koshida, K; Kunimi, K; Uchibayashi, T; Yamamoto, H	1

Trials

1 trial(s) available for 3-ft and Bladder Cancer

Article	Year
Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin. International journal of clinical pharmacology and therapeutics, 1995, Volume: 33, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Female; Humans; Isomerism; Leucine; Male; Middle Aged; Prospective Studies; Tegafur; Urinary Bladder Neoplasms	1995

Article

Year

Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin.

International journal of clinical pharmacology and therapeutics, 1995, Volume: 33, Issue:8

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Female; Humans; Isomerism; Leucine; Male; Middle Aged; Prospective Studies; Tegafur; Urinary Bladder Neoplasms

1995